Foley, a transportation compliance firm, created ProSight’s drug testing program to help identify drivers and machine operators that use drugs not monitored in a typical Department of Transportation drug test.
The companies say that statistics show the current DOT-compliant drug screen panel does not include many contemporary drugs that can lead to accidents and undesirable driver behaviors.
ProSight’s Drug Testing Program powered by Foley includes three options for policyholders at a discount off of retail pricing:
- Enhanced Drug Testing package
- An enhanced 10-panel drug test that uncovers risky pharmaceutical drugs that account for 30 percent of post-accident positive tests and is 2-3 times more likely to return a positive result
- Nationwide network of 9,000 testing centers
- Faster than average results when compared to industry standards
- Driver File Management package. This includes the Enhanced Drug Testing package above plus:
- Maintenance of all DOT driver files in audit ready format
- Tracking motor vehicle records
- Storing cognitive/medical assessments
- Handling background checks
- Basic DOT testing package
- Includes the standard DOT-compliance test administered by Foley
“ProSight is fully committed to working with industry experts to solve problems that affect our transportation customers,” says Jeremy Zottneck, president of ProSight’s transportation niche. “We’re very excited to partner with Foley to offer an enhanced drug test that will help customers boost their productivity, reduce driver churn, decrease dangerous incidents and improve overall ROI.”
